Integrated laboratory evolution and rational engineering of GalP/Glk-dependent Escherichia coli for higher yield and productivity of L-tryptophan biosynthesis

IF 3.7 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Chen Minliang, Ma Chengwei, Chen Lin, An-Ping Zeng
{"title":"Integrated laboratory evolution and rational engineering of GalP/Glk-dependent Escherichia coli for higher yield and productivity of L-tryptophan biosynthesis","authors":"Chen Minliang,&nbsp;Ma Chengwei,&nbsp;Chen Lin,&nbsp;An-Ping Zeng","doi":"10.1016/j.mec.2021.e00167","DOIUrl":null,"url":null,"abstract":"<div><p>L-Tryptophan (Trp) is a high-value aromatic amino acid with diverse applications in food and pharmaceutical industries. Although production of Trp by engineered <em>Escherichia coli</em> has been extensively studied, the need of multiple precursors for its synthesis and the complex regulations of the biosynthetic pathways make the achievement of a high product yield still very challenging. Metabolic flux analysis suggests that the use of a phosphoenolpyruvate:sugar phosphotransferase system (PTS) independent glucose uptake system, i.e. the galactose permease/glucokinase (GalP/Glk) system, can theoretically double the Trp yield from glucose. To explore this possibility, a PTS<sup>−</sup> and GalP/Glk-dependent <em>E. coli</em> strain was constructed from a previously rationally developed Trp producer strain S028. However, the growth rate of the S028 mutant was severely impaired. To overcome this problem, promoter screening for modulated gene expression of GalP/Glk was carried out, following by a batch mode of adaptive laboratory evolution (ALE) which resulted in a strain K3 with a similar Trp yield and concentration as S028. In order to obtain a more efficient Trp producer, a novel continuous ALE system was developed by combining CRISPR/Cas9-facilitated <em>in vivo</em> mutagenesis with real-time measurement of cell growth and online monitoring of Trp-mediated fluorescence intensity. With the aid of this automatic system (auto-CGSS), a promising strain T5 was obtained and fed-batch fermentations showed an increase of Trp yield by 19.71% with this strain compared with that obtained by the strain K3 (0.164 vs. 0.137 ​g/g). At the same time, the specific production rate was increased by 52.93% (25.28 vs. 16.53 ​mg/g <sub>DCW</sub>/h). Two previously engineered enzyme variants AroG<sup>D6G−D7A</sup> and <em>An</em>TrpC<sup>R378F</sup> were integrated into the strain T5, resulting in a highly productive strain T5AA with a Trp yield of 0.195 ​g/g and a specific production rate of 28.83 ​mg/g <sub>DCW</sub>/h.</p></div>","PeriodicalId":18695,"journal":{"name":"Metabolic Engineering Communications","volume":"12 ","pages":"Article e00167"},"PeriodicalIF":3.7000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.mec.2021.e00167","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic Engineering Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2214030121000079","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 14

Abstract

L-Tryptophan (Trp) is a high-value aromatic amino acid with diverse applications in food and pharmaceutical industries. Although production of Trp by engineered Escherichia coli has been extensively studied, the need of multiple precursors for its synthesis and the complex regulations of the biosynthetic pathways make the achievement of a high product yield still very challenging. Metabolic flux analysis suggests that the use of a phosphoenolpyruvate:sugar phosphotransferase system (PTS) independent glucose uptake system, i.e. the galactose permease/glucokinase (GalP/Glk) system, can theoretically double the Trp yield from glucose. To explore this possibility, a PTS and GalP/Glk-dependent E. coli strain was constructed from a previously rationally developed Trp producer strain S028. However, the growth rate of the S028 mutant was severely impaired. To overcome this problem, promoter screening for modulated gene expression of GalP/Glk was carried out, following by a batch mode of adaptive laboratory evolution (ALE) which resulted in a strain K3 with a similar Trp yield and concentration as S028. In order to obtain a more efficient Trp producer, a novel continuous ALE system was developed by combining CRISPR/Cas9-facilitated in vivo mutagenesis with real-time measurement of cell growth and online monitoring of Trp-mediated fluorescence intensity. With the aid of this automatic system (auto-CGSS), a promising strain T5 was obtained and fed-batch fermentations showed an increase of Trp yield by 19.71% with this strain compared with that obtained by the strain K3 (0.164 vs. 0.137 ​g/g). At the same time, the specific production rate was increased by 52.93% (25.28 vs. 16.53 ​mg/g DCW/h). Two previously engineered enzyme variants AroGD6G−D7A and AnTrpCR378F were integrated into the strain T5, resulting in a highly productive strain T5AA with a Trp yield of 0.195 ​g/g and a specific production rate of 28.83 ​mg/g DCW/h.

Abstract Image

Abstract Image

Abstract Image

GalP/ glk依赖性大肠杆菌的综合实验室进化和合理工程,提高l -色氨酸生物合成的产量和生产力
l -色氨酸(Trp)是一种高价值的芳香氨基酸,在食品和制药工业中有着广泛的应用。尽管利用工程大肠杆菌生产色氨酸已经得到了广泛的研究,但合成色氨酸需要多种前体,生物合成途径的复杂调控使得实现高产量仍然非常具有挑战性。代谢通量分析表明,使用磷酸烯醇丙酮酸:糖磷酸转移酶系统(PTS)独立的葡萄糖摄取系统,即半乳糖渗透酶/葡萄糖激酶(GalP/Glk)系统,理论上可以使葡萄糖的色氨酸产量翻倍。为了探索这种可能性,我们利用先前合理开发的色氨酸产生菌S028构建了依赖PTS -和GalP/ glk的大肠杆菌菌株。然而,S028突变体的生长速率严重受损。为了克服这一问题,我们对GalP/Glk调控基因表达的启动子进行了筛选,然后进行了批量适应实验室进化(ALE)模式,结果菌株K3具有与S028相似的Trp产量和浓度。为了获得更高效的色氨酸产生物,我们将CRISPR/ cas9介导的体内诱变与实时测量细胞生长和在线监测色氨酸介导的荧光强度相结合,开发了一种新型的连续ALE系统。在该自动系统(auto-CGSS)的辅助下,获得了一个很有前途的菌株T5,与菌株K3相比,该菌株的色氨酸产量提高了19.71% (0.164 g/g比0.137 g/g)。同时,比产率提高52.93%(25.28比16.53 mg/g DCW/h)。将先前设计的两种酶变体AroGD6G−D7A和AnTrpCR378F整合到菌株T5中,得到了Trp产量为0.195 g/g,比产率为28.83 mg/g DCW/h的高产菌株T5AA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Metabolic Engineering Communications
Metabolic Engineering Communications Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
13.30
自引率
1.90%
发文量
22
审稿时长
18 weeks
期刊介绍: Metabolic Engineering Communications, a companion title to Metabolic Engineering (MBE), is devoted to publishing original research in the areas of metabolic engineering, synthetic biology, computational biology and systems biology for problems related to metabolism and the engineering of metabolism for the production of fuels, chemicals, and pharmaceuticals. The journal will carry articles on the design, construction, and analysis of biological systems ranging from pathway components to biological complexes and genomes (including genomic, analytical and bioinformatics methods) in suitable host cells to allow them to produce novel compounds of industrial and medical interest. Demonstrations of regulatory designs and synthetic circuits that alter the performance of biochemical pathways and cellular processes will also be presented. Metabolic Engineering Communications complements MBE by publishing articles that are either shorter than those published in the full journal, or which describe key elements of larger metabolic engineering efforts.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信